SCHEMBL20061222

SCHEMBL20061222

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1c(-n2c3ccccc3c3cc(-n4c5ccccc5c5ccccc54)ccc32)cc(C#N)cc1-n1c2ccccc2c2cc(-n3c4ccccc4c4ccccc43)ccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
ATM Q13315 1/20 0.34
BCHE P06276 1/20 0.34
ACHE P22303 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
CASP1 P29466 1/20 0.34
HSD17B10 Q99714 1/20 0.34
USP14 P54578 2/20 0.33
RORC P51449 5/20 0.33
PTGER4 P35408 2/20 0.33
IMPDH2 P12268 1/20 0.32
F2 P00734 1/20 0.31
PLAU P00749 1/20 0.31
ELANE P08246 1/20 0.31
CTRB1 P17538 1/20 0.31
PGR P06401 1/20 0.31
RORA P35398 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20061220 0.92 KDM4E (0.40) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL20061219 0.88 USP14 (0.35) KDM4EL3MBTL1ATMBCHEACHE
SCHEMBL19823513 0.88 USP14 (0.35) KDM4EL3MBTL1ATMBCHEACHE
SCHEMBL20437429 0.88 BCHE (0.35) KDM4EL3MBTL1BCHEACHEALDH1A1
SCHEMBL20061235 0.87 ALDH1A1 (0.38) KDM4EBCHEACHEALDH1A1USP14
SCHEMBL25513395 0.83 BCHE (0.40) KDM4EL3MBTL1BCHEACHEALDH1A1
SCHEMBL17565589 0.83 USP14 (0.45) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL20086150 0.83 PTGER4 (0.35) KDM4EL3MBTL1ATMBCHEACHE
SCHEMBL20061224 0.83 RORC (0.38) KDM4EL3MBTL1BCHEACHEALDH1A1
SCHEMBL19809918 0.83 IMPDH2 (0.40) KDM4EL3MBTL1ATMALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11239439-B2 Material for organic electroluminescent device, light-emitting material, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2022-02-01 US disclosed
US-20180108857-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE, LIGHT-EMITTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE KYULUX, INC. (JP) 2018-04-19 US disclosed
US-20180108857-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE, LIGHT-EMITTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE KYULUX, INC. (JP) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11239439-B2 Material for organic electroluminescent device, light-emitting material, and organic electroluminescent device LEF1, POU2F1, L3MBTL1 KDM4E 836/4885L3MBTL1 3/4885ATM 4137/4885
US-20180108857-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE, LIGHT-EMITTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE LEF1, POU2F1, L3MBTL1 KDM4E 836/4885L3MBTL1 3/4885ATM 4137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.